J&J, GSK rheumatoid arthritis drug meets goals of large trial
An experimental drug for rheumatoid arthritis developed by Johnson & Johnson and GlaxoSmithKline slowed joint damage and improved symptoms of the disease, meeting the main goals of a large, late s...